• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期嵌合阈值可预测产前异基因嵌合体的持续植入和自然杀伤细胞耐受性。

Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras.

作者信息

Durkin Emily T, Jones Kelly A, Rajesh Deepika, Shaaban Aimen F

机构信息

Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, USA.

出版信息

Blood. 2008 Dec 15;112(13):5245-53. doi: 10.1182/blood-2007-12-128116. Epub 2008 Sep 16.

DOI:10.1182/blood-2007-12-128116
PMID:18796629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2597617/
Abstract

The failure of engraftment in human cases of in utero hematopoietic cell transplantation (IUHCT) in which no immunodeficiency exists suggests the presence of an unrecognized fetal immune barrier. A similar barrier in murine IUHCT appears to be dependent on the chimerism level and is poorly explained by a lack of T-cell tolerance induction. Therefore, we studied the effect of the chimerism level on engraftment and host natural killer (NK)-cell education in a murine model of IUHCT. The dose of transplanted cells was found to exhibit a strong correlation with both the engraftment rate and chimerism level. More specifically, a threshold level of initial chimerism (> 1.8%) was identified that predicted durable engraftment for allogeneic IUHCT, whereas low initial chimerism (< 1.8%) predicted a loss of engraftment. NK cells taken from chimeras above the "chimerism threshold" displayed durable calibration of alloresponsive Ly49A receptors and tolerance to donor antigens. Depletion of recipient NK cells stabilized engraftment in low-level chimeras (< 1.8%). These studies illustrate the importance of the early chimerism threshold in predicting long-term engraftment and host NK-cell tolerance after in utero transplantation.

摘要

在不存在免疫缺陷的人类子宫内造血细胞移植(IUHCT)病例中,植入失败提示存在未被识别的胎儿免疫屏障。小鼠IUHCT中的类似屏障似乎取决于嵌合水平,并且缺乏T细胞耐受性诱导难以解释这一现象。因此,我们在小鼠IUHCT模型中研究了嵌合水平对植入以及宿主自然杀伤(NK)细胞驯化的影响。发现移植细胞剂量与植入率和嵌合水平均密切相关。更具体地说,确定了初始嵌合的阈值水平(>1.8%),该阈值可预测异基因IUHCT的持久植入,而低初始嵌合(<1.8%)则预示植入失败。取自高于“嵌合阈值”的嵌合体中的NK细胞表现出对同种异体反应性Ly49A受体的持久校准以及对供体抗原的耐受性。受体NK细胞的耗竭可稳定低水平嵌合体(<1.8%)中的植入。这些研究说明了早期嵌合阈值在预测子宫内移植后长期植入和宿主NK细胞耐受性方面的重要性。

相似文献

1
Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras.早期嵌合阈值可预测产前异基因嵌合体的持续植入和自然杀伤细胞耐受性。
Blood. 2008 Dec 15;112(13):5245-53. doi: 10.1182/blood-2007-12-128116. Epub 2008 Sep 16.
2
Prenatal transplantation of cytokine-stimulated marrow improves early chimerism in a resistant strain combination but results in poor long-term engraftment.细胞因子刺激的骨髓进行产前移植可改善抗性品系组合中的早期嵌合现象,但长期植入效果不佳。
Exp Hematol. 2006 Sep;34(9):1278-87. doi: 10.1016/j.exphem.2006.05.007.
3
CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation.CD26抑制可增强宫内造血细胞移植后同种异体供体细胞的归巢和植入。
Blood. 2006 Dec 15;108(13):4268-74. doi: 10.1182/blood-2006-04-018986. Epub 2006 Sep 5.
4
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation.输注宿主来源的未经许可的自然杀伤细胞可改善非清髓性异基因造血细胞移植中的供体植入。
Front Immunol. 2021 Jan 7;11:614250. doi: 10.3389/fimmu.2020.614250. eCollection 2020.
5
Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras.同种异体H-2d→H-2b和H-2b→H-2d骨髓嵌合体中供体和受体Ly49+自然杀伤细胞亚群的改变
J Immunol. 1999 Dec 1;163(11):5896-905.
6
Trogocytosis as a mechanistic link between chimerism and prenatal tolerance.作为嵌合现象与产前耐受性之间机制联系的细胞互食作用
Chimerism. 2013 Oct-Dec;4(4):126-31. doi: 10.4161/chim.26666. Epub 2013 Oct 11.
7
Maternal Administration of Busulfan before in Utero Hematopoietic Cell Transplantation Improves Congenic Bone Marrow Cell Engraftment in a Murine Model.母体给予白消安预处理可提高同种异体骨髓细胞在小鼠模型中的植入
Transplant Cell Ther. 2024 Apr;30(4):398.e1-398.e10. doi: 10.1016/j.jtct.2024.01.081. Epub 2024 Feb 6.
8
Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.通过宫内造血干细胞移植和出生后供体淋巴细胞输注的联合策略实现完全异基因造血嵌合。
Blood. 2002 Aug 1;100(3):804-12. doi: 10.1182/blood-2002-01-0016.
9
Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice.母体同种异体抗体诱导产后免疫反应,限制小鼠宫内造血细胞移植后的植入。
J Clin Invest. 2009 Sep;119(9):2590-600. doi: 10.1172/JCI38979. Epub 2009 Aug 3.
10
Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.通过宫内造血细胞移植以及经低剂量甲氨蝶呤处理、MHC致敏的供体淋巴细胞共移植实现完全异基因造血嵌合。
Exp Hematol. 2004 Mar;32(3):290-9. doi: 10.1016/j.exphem.2003.12.008.

引用本文的文献

1
Immune modulation permits tolerance and engraftment in a murine model of late-gestation transplantation.免疫调节可允许在晚期妊娠移植的小鼠模型中耐受和植入。
Blood Adv. 2024 Sep 10;8(17):4523-4538. doi: 10.1182/bloodadvances.2023012247.
2
Maternal dendritic cells influence fetal allograft response following murine in-utero hematopoietic stem cell transplantation.母源树突状细胞影响小鼠子宫内造血干细胞移植后胎儿同种异体移植物反应。
Stem Cell Res Ther. 2023 May 24;14(1):136. doi: 10.1186/s13287-023-03366-9.
3
Experimental and clinical progress of in utero hematopoietic cell transplantation therapy for congenital disorders.先天性疾病宫内造血细胞移植治疗的实验与临床进展
Front Pharmacol. 2022 Sep 2;13:851375. doi: 10.3389/fphar.2022.851375. eCollection 2022.
4
Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity.非免疫细胞间的胞饮作用可用于细胞清除,免疫相关细胞间的胞饮作用可用于调节免疫应答和自身免疫。
Int J Mol Sci. 2021 Feb 24;22(5):2236. doi: 10.3390/ijms22052236.
5
Maternal microchimerism and cell-mediated immune-modulation enhance engraftment following semi-allogenic intrauterine transplantation.母源微嵌合体和细胞介导的免疫调节增强半同种子宫内移植后的植入。
FASEB J. 2021 Mar;35(3):e21413. doi: 10.1096/fj.202002185RR.
6
Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System.镰状细胞病的治疗方法:利用胎儿免疫系统
Front Cell Dev Biol. 2021 Jan 22;8:624477. doi: 10.3389/fcell.2020.624477. eCollection 2020.
7
Maternal and Fetal Immune Response to in Utero Stem Cell Transplantation.母胎对子宫内干细胞移植的免疫反应。
Curr Stem Cell Rep. 2018 Jun;4(2):182-187. doi: 10.1007/s40778-018-0129-5. Epub 2018 May 3.
8
Depletion of murine fetal hematopoietic stem cells with c-Kit receptor and CD47 blockade improves neonatal engraftment.阻断 c-Kit 受体和 CD47 耗竭可提高新生鼠造血干细胞的植入率。
Blood Adv. 2018 Dec 26;2(24):3602-3607. doi: 10.1182/bloodadvances.2018022020.
9
A comparison of intrauterine hemopoietic cell transplantation and lentiviral gene transfer for the correction of severe β-thalassemia in a HbbTh3/+ murine model.在HbbTh3/+小鼠模型中,宫内造血细胞移植与慢病毒基因转移治疗重度β地中海贫血的比较。
Exp Hematol. 2018 Jun;62:45-55. doi: 10.1016/j.exphem.2018.03.006. Epub 2018 Mar 29.
10
Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells.经人类造血干细胞宫内移植后,小鼠出现系统性多谱系嵌合体。
Blood Adv. 2018 Jan 5;2(1):69-74. doi: 10.1182/bloodadvances.2017011585. eCollection 2018 Jan 9.

本文引用的文献

1
High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity.NKG2A/CD94的高表达和颗粒酶B的低表达与脐带血自然杀伤细胞活性降低有关。
Cell Mol Immunol. 2007 Oct;4(5):377-82.
2
Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC.人类孕早期胎儿间充质干细胞表达多能性标志物,并且比成人间充质干细胞生长更快,端粒更长。
Stem Cells. 2007 Mar;25(3):646-54. doi: 10.1634/stemcells.2006-0208. Epub 2006 Nov 22.
3
Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.发育中的人类自然杀伤细胞对抑制性和激活性受体的协同获取及功能特性
Blood. 2006 Dec 1;108(12):3824-33. doi: 10.1182/blood-2006-04-020198. Epub 2006 Aug 10.
4
Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation.白消安预处理的骨髓移植在经宫内造血细胞移植诱导耐受的小鼠中可导致高水平的异基因嵌合。
Exp Hematol. 2006 Mar;34(3):359-68. doi: 10.1016/j.exphem.2005.11.011.
5
NK cells play a critical role in the regulation of class I-deficient hemopoietic stem cell engraftment: evidence for NK tolerance correlates with receptor editing.自然杀伤细胞在I类缺陷造血干细胞植入的调节中起关键作用:自然杀伤细胞耐受性的证据与受体编辑相关。
J Immunol. 2005 Sep 15;175(6):3753-61. doi: 10.4049/jimmunol.175.6.3753.
6
Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta.严重成骨不全症患者宫内移植后胎儿间充质干细胞在骨内的植入
Transplantation. 2005 Jun 15;79(11):1607-14. doi: 10.1097/01.tp.0000159029.48678.93.
7
Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance.免疫预处理和 MHC 不匹配的干细胞移植后的长期混合嵌合状态依赖于自然杀伤细胞的耐受性。
Blood. 2005 Sep 15;106(6):2215-20. doi: 10.1182/blood-2005-04-1391. Epub 2005 May 31.
8
CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.CD56dimCD16neg细胞负责对肿瘤靶标的天然细胞毒性。
Leukemia. 2005 May;19(5):835-40. doi: 10.1038/sj.leu.2403704.
9
In utero transplantation: baby steps towards an effective therapy.子宫内移植:迈向有效治疗的初步进展。
Bone Marrow Transplant. 2005 Mar;35(6):537-47. doi: 10.1038/sj.bmt.1704811.
10
CD107a as a functional marker for the identification of natural killer cell activity.CD107a作为鉴定自然杀伤细胞活性的功能标志物。
J Immunol Methods. 2004 Nov;294(1-2):15-22. doi: 10.1016/j.jim.2004.08.008.